Patents by Inventor Weiyan Xiong

Weiyan Xiong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11091485
    Abstract: Provided is an imidazo[1?,2?:1,6]pyrido[2,3-d]pyrimidine compound of general formula (I). The compound can be used in treating a cell proliferative disorder and is a cyclin-dependent kinase (CDK) inhibitor with broad-spectrum and strong activity.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: August 17, 2021
    Assignee: SHENGKE PHARMACEUTICALS (JIANGSU) LTD.
    Inventors: Bin Liu, Hang Cheng, Weiyan Xiong, Chenggang Zhang, Chengzhi Yu
  • Publication number: 20210147424
    Abstract: A 1H-pyrazolo[4,3-H]quinazoline compound represented by formula (I) can be used for treating cell proliferation dysfunction, and is an broad-spectrum and strongly-active inhibitor for a cell cyclin-dependent kinase (CDK).
    Type: Application
    Filed: August 10, 2018
    Publication date: May 20, 2021
    Inventors: Bin Liu, Hang Cheng, Weiyan Xiong, Chenggang Zhang, Chengzhi Yu
  • Publication number: 20200270251
    Abstract: Provided is an imidazo[1?;2?:1,6]pyrido[2,3-d]pyrimidine compound of general formula (I). The compound can be used in treating a cell proliferative disorder and is a cyclin-dependent kinase (CDK) inhibitor with broad-spectrum and strong activity.
    Type: Application
    Filed: May 21, 2018
    Publication date: August 27, 2020
    Inventors: Bin Liu, Hang Cheng, Weiyan Xiong, Chenggang Zhang, Chengzhi Yu